Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1998 | 12-1997 | 09-1997 | 06-1997 | 03-1997 | |
| Sales | 547 | 2,210 | 576 | 552 | 531 |
| Gross Profit | 540 | 2,210 | 0 | 0 | 0 |
| Operating Expenses | 2,410 | 2,995 | 2,139 | 2,979 | 2,207 |
| Operating Income | -1,863 | -785 | -1,563 | -2,427 | -1,676 |
| Other Income | -7 | -1,659 | 0 | 0 | 0 |
| Pre-tax Income | -1,870 | -2,444 | -1,563 | -2,427 | -1,676 |
| Net Income Continuous | -1,871 | -2,400 | -1,563 | -2,427 | -1,676 |
| Net Income | $-1,871 | $-2,400 | $-1,563 | $-2,427 | $-1,676 |
| EPS Basic Total Ops | -43.22 | -57.62 | -38.42 | -60.02 | -43.22 |
| EPS Basic Continuous Ops | -44.02 | -57.55 | -38.40 | -60.07 | -43.20 |
| EPS Diluted Total Ops | -43.22 | -57.62 | -38.42 | -60.02 | -43.22 |
| EPS Diluted Continuous Ops | -44.02 | -57.55 | -38.40 | -60.07 | -43.20 |
| EBITDA(a) | $-1,843 | $-785 | $-1,541 | $-2,413 | $-1,669 |